Health Canada
Symbol of the Government of Canada
First Nations, Inuit and Aboriginal Health

Drug Benefit List 2010

10:00 ANTINEOPLASTIC AGENTS

10:00.00 ANTINEOPLASTIC AGENTS

ALTRETAMINE

50mg Capsule
2126230 HEXALEN LIL

ANASTROZOLE

1mg Tablet
2224135 ARIMIDEX AZC

BICALUTAMIDE

50mg Tablet
2296063 APO-BICALUTAMIDE APX
2184478 CASODEX AZC
2274337 CO BICALUTAMIDE COB
2302403 GEN-BICALUTAMIDE GEN
2270226 NOVO-BICALUTAMIDE NOP
2275589 PMS-BICALUTAMIDE PMS
2311038 PRO-BICALUTAMIDE PDL
2277700 RATIO-BICALUTAMIDE RPH
2276089 SANDOZ-BICALUTAMIDE SDZ

BUSERELIN ACETATE

1mg/mL Injection
2225166 SUPREFACT SAC
1mg/mL Nasal Solution
2225158 SUPREFACT SAC
6.3mg/Implant Subcutaneous Injection
2228955 SUPREFACT DEPOT 2 MONTHS SAC
9.45mg/Implant Subcutaneous Injection
2240749 SUPREFACT DEPOT 3 MONTHS SAC

BUSULFAN

2mg Tablet
4618 MYLERAN GSK

CAPECITABINE

150mg Tablet
2238453 XELODA HLR
500mg Tablet
2238454 XELODA HLR

CHLORAMBUCIL

2mg Tablet
4626 LEUKERAN GSK

CYCLOPHOSPHAMIDE

25mg Tablet
2241795 PROCYTOX BAT
50mg Tablet
344885 CYTOXAN BMS
2241796 PROCYTOX BAT

CYPROTERONE ACETATE

50mg Tablet
704431 ANDROCUR BEX
2245898 APO-CYPROTERONE APX
2229723 GEN-CYPROTERONE GEN

ERLOTINIB HYDROCLORIDE

Limited use benefit (prior approval required).

Treatment of non-small cell lung cancer (NSCLC) after failure of at least one prior chemotherapy regimen, and whose EGFR expression status is positive or unknown.

100mg Tablet
2269015 TARCEVA HLR
150mg Tablet
2269023 TARCEVA HLR

ETOPOSIDE

50mg Capsule
616192 VEPESID BMS

EXEMESTANE

25mg Tablet
2242705 AROMASIN PFI

FLUDARABINE PHOSPHATE

10mg Tablet
2246226 FLUDARA BEX

FLUTAMIDE

250mg Tablet
2238560 APO-FLUTAMIDE APX
637726 EUFLEX SCH
2230089 NOVO-FLUTAMIDE NOP
2239388 PDL-FLUTAMIDE PDL
2230104 PMS-FLUTAMIDE PMS

GOSERELIN ACETATE

3.6mg/Depot Injection
2049325 ZOLADEX AZC
10.8mg/Depot Injection
2225905 ZOLADEX LA AZC

HYDROXYUREA

500mg Capsule
2247937 APO-HYDROXYUREA APX
2242920 GEN-HYDROXYUREA GEN
500mg Tablet
465283 HYDREA BMS

IMATINIB MESYLATE

Limited use benefit (prior approval required).

  1. For the treatment of patients with chronic myeloid leukemia in blast crisis, accelerated phase, or in chronic phase after failure of interferon-alpha therapy.
  2. For the treatment of patients with gastrointestinal stromal tumour.
  3. For newly diagnosed adult patients with Philadelphia chromosome-positive chronic myeloid leukemia (CML).
100mg Tablet
2253275 GLEEVEC NVR
400mg Tablet
2253283 GLEEVEC NOV

INTERFERON ALFA-2B

6,000,000IU/mL Injection
2238674 INTRON A SCH
10,000,000IU/mL Injection
2238675 INTRON A SCH
10,000,000IU/Vial Injection
2223406 INTRON A SCH
15,000,000IU/mL Injection
2240693 INTRON A SCH
18,000,000IU/Vial Injection
2231651 INTRON A SCH
25,000,000IU/mL Injection
2240694 INTRON A SCH
50,000,000IU/mL Injection
2240695 INTRON A SCH

LETROZOLE

2.5mg Tablet
2231384 FEMARA NVR
2348969 LETROZOLE CBT
2309114 PMS-LETROZOLE PMS
2344815 SANDOZ LETROZOLE SDZ

LEUPROLIDE ACETATE

3.75mg/Vial Injection
884502 LUPRON DEPOT ABB
7.5mg/Vial Injection
836273 LUPRON DEPOT ABB
11.25mg/Vial Injection
2239834 LUPRON DEPOT ABB
22.5mg/Vial Injection
2248240 ELIGARD SAC
2230248 LUPRON DEPOT ABB
30mg/Vial Injection
2248999 ELIGARD SAC
2239833 LUPRON DEPOT ABB
45mg/Vial Injection
2268892 ELIGARD SAC

LOMUSTINE

10mg Capsule
360430 CEENU BMS

LOMUSTINE

40mg Capsule
360422 CEENU BMS
100mg Capsule
360414 CEENU BMS

MEGESTROL ACETATE

40mg/mL Suspension
2168979 MEGACE BMS
40mg Tablet
2195917 APO-MEGESTROL APX
2223104 MEGESTROL PDL
2185415 NU-MEGESTROL NXP
160mg Tablet
2195925 APO-MEGESTROL APX
731323 MEGACE BMS
2223112 MEGESTROL PDL
2185423 NU-MEGESTROL NXP

MELPHALAN

2mg Tablet
4715 ALKERAN GSK

MERCAPTOPURINE

50mg Tablet
4723 PURINETHOL NOP

METHOTREXATE SODIUM

10mg/mL Injection
2182947 METHOTREXATE MAY
25mg/mL Injection
2182777 METHOTREXATE MAY
2182955 METHOTREXATE MAY
2099705 NOVO-METHOTREXATE NOP
2.5mg Tablet
2182963 APO-METHOTREXATE APX
2170698 METHOTREXATE WAY
2244798 RATIO-METHOTREXATE RPH
10mg Tablet
2182750 METHOTREXATE MAY

MITOTANE

500mg Tablet
463221 LYSODREN BMS

NILUTAMIDE

50mg Tablet
2221861 ANANDRON SAC

PROCARBAZINE HCL

50mg Capsule
12750 NATULAN SIG

RITUXIMAB

Limited use benefit (prior approval required).

Prescribed by a rheumatologist for treatment of adult patients with severely active rheumatoid arthritis who have failed to respond to a trial of an anti-TNF agent. Treatment should be combined with methotrexate. Rituximab should not be used in combination with anti-TNF agents.

Treatment beyond six months will only be considered for patients who have achieved a response. (Please refer to Appendix A).

10mg/mL Injection
2241927 RITUXAN HLR

SUNITINIB MALATE

Limited use benefit (Prior approval required)

Criteria for initial six month coverage of Sutent:
For patients with histologically proven unresectable or recurrent/metastatic GIST who have failed or are unable to tolerate imatinib therapy. Sunitinib will not be funded concomitantly with imatinib.

Criteria for assessment at every six months:
There is no objective evidence of disease progression.

12.5mg Capsule
2280795 SUTENT PFI
25mg Capsule
2280809 SUTENT PFI
50mg Capsule
2280817 SUTENT PFI

TAMOXIFEN CITRATE

10mg Tablet
812404 APO-TAMOX APX
2088428 GEN-TAMOXIFEN GEN
851965 NOVO-TAMOXIFEN NOP
2237459 PMS-TAMOXIFEN PMS
1926624 TAMOFEN SAC
2296721 TAMOXIFEN PDL
20mg Tablet
812390 APO-TAMOX APX
2089858 GEN-TAMOXIFEN GEN
2048485 NOLVADEX D AZC
851973 NOVO-TAMOXIFEN NOP
2237460 PMS-TAMOXIFEN PMS
1926632 TAMOFEN SAC
2296748 TAMOXIFEN PDL

TEMOZOLOMIDE

Limited use benefit (prior approval required).

For:

  1. treatment of adult patients with glioblastoma multiforme or anaplastic astrocytoma, and documented evidence of recurrence or progression after standard therapy (resection, radiotherapy, and chemotherapy).
  2. treatment of adult patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as maintenance treatment.
5mg Capsule
2241093 TEMODAL SCH
20mg Capsule
2241094 TEMODAL SCH
100mg Capsule
2241095 TEMODAL SCH
250mg Capsule
2241096 TEMODAL SCH

THIOGUANINE

40mg Tablet
282081 LANVIS GSK

TRETINOIN

10mg Capsule
2145839 VESANOID HLR

TRIPTORELIN PAMOATE

3.75mg/Vial Injection
2240000 TRELSTAR WAT
11.25mg/Vial Injection
2243856 TRELSTAR LA WAT

VINCRISTINE SULFATE

1mg/mL Injection
2143305 VINCRISTINE SULFATE NOP
2183013 VINCRISTINE SULFATE MAY